Causes of Secondary and Prolonged Fever During Treatment of Bacterial Meningitis and Viral Encephalitis
1 other identifier
observational
50
0 countries
N/A
Brief Summary
The aim of the present study is to investigate causes of secondary and prolonged fever during treatment of viral encephalitis and bacterial meningitis in children aged from one month to 18 years .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedFirst Posted
Study publicly available on registry
May 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedMay 14, 2025
May 1, 2025
11 months
April 29, 2025
May 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Causes of secondary and prolonged fever during treatment of bacterial meningitis and viral encephalitis
Causes of secondary and prolonged fever during treatment of bacterial meningitis and viral encephalitis
Basline
Eligibility Criteria
Included children aged from one month to 18 years , who were diagnosed as bacterial meningitis or viral encephalitis and admitted to neurological department at AUCH and develop secondary or prolonged fever despite appropriate treatment .
You may qualify if:
- Children from one month to 18 years.
- Who were diagnosed with bacterial meningitis or viral encephalitis and admitted to neurological department at Assiut University Children's Hospital (AUCH).
- Develop secondary or prolonged fever despite appropriate treatment.
You may not qualify if:
- Pediatric patients with suspected autoimmune encephalitis.
- Patient on immunosuppressive therapy (e.g., post-organ transplant, chemotherapy).
- Pediatric patients suspected metabolic disorders.
- Those with suspected endocrine dysfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Brouwer MC, McIntyre P, de Gans J, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2010 Sep 8;(9):CD004405. doi: 10.1002/14651858.CD004405.pub3.
PMID: 20824838BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Prof. Mostafa Shafeek Khalaf Tawfeek, Professor of Pediatrics
Assiut University
- PRINCIPAL INVESTIGATOR
Dr. Khalaf Abd El-Aal Sayed Mohamed, Lecturer of Pediatrics
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
April 29, 2025
First Posted
May 14, 2025
Study Start
May 1, 2025
Primary Completion
April 1, 2026
Study Completion
May 1, 2026
Last Updated
May 14, 2025
Record last verified: 2025-05